Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.162NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Y.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Y.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Y.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Y.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.86ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.86NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.154ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.154ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.154ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.154NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.137ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.137ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.137ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.137NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.446ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.446ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.446ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.446NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.76 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.76 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.76 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.76 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.398ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.398ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.398ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.398NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.163ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.163ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.163NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.3 (Theta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.3 (Theta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.3 (Theta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.3 (Theta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used